Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -1.37% | 72.85 | 1.0% | $2085.84m | |
| AMGN | Amgen, Inc. | -0.11% | 198.27 | 1.3% | $912.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.62% | 449.52 | 2.6% | $775.54m | |
| BIIB | Biogen, Inc. | -2.69% | 296.75 | 1.5% | $711.86m | |
| MRNA | Moderna, Inc. | 7.55% | 30.05 | 0.0% | $640.21m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -3.23% | 217.24 | 1.9% | $526.89m | |
| ILMN | Illumina, Inc. | -1.96% | 269.05 | 3.5% | $482.68m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.47% | 84.01 | 2.0% | $265.76m | |
| A | Agilent Technologies, Inc. | -3.61% | 71.06 | 1.6% | $237.61m | |
| EXAS | EXACT Sciences Corp. | -4.91% | 57.90 | 21.0% | $205.46m | |
| INCY | Incyte Corp. | -5.60% | 68.96 | 2.5% | $167.54m | |
| SGEN | Seattle Genetics, Inc. | -5.92% | 109.27 | 6.1% | $162.29m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -3.79% | 79.51 | 4.3% | $160.35m | |
| NVAX | Novavax, Inc. | 2.43% | 13.05 | 114.7% | $149.95m | |
| CODX | Co-Diagnostics, Inc. | -2.66% | 9.15 | 0.0% | $148.50m |
Company Profile
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.